ENTA

7.6204.51%
JR

Jay R. Luly

President, CEO & Director

Dr. Jay R. Luly, Ph.D., has been the Chief Executive Officer, President and Director of Enanta Pharmaceuticals, Inc. since July 2003. Dr. Luly joined Enanta in July 2003. Previously he was employed at Oxford Bioscience Partners as an Entrepreneur in Residence. Before joining Oxford in March 2002, Dr. Luly served as Senior Vice President of R&D Operations and Senior Vice President of Discovery Strategy and Operations of Millennium Pharmaceuticals, following Millennium Pharmaceuticals, Inc. merger with LeukoSite, Inc., where he served as Senior Vice President of Drug Discovery and Pre-Clinical Development. Dr. Luly served as Vice President of Drug Discovery at LeukoSite, Inc. prior to joining LeukoSite, he held a number of senior drug discovery positions at Abbott Laboratories from 1983 to 1997. His Research and development efforts have resulted in several therapeutics reaching clinical development and he is an inventor on 45 issued U.S. patents and has authored over 150 scientific publications, abstracts and review articles. He served as a Director of Artesian Therapeutics, Inc. He serves as a Trustee of Boston Biomedical Research Institute, Inc. Dr. Luly earned a B.S. in Chemistry with highest distinction from University of Illinois, Urbana/Champaign and a Ph.D. in synthetic organic chemistry from University of California, Berkeley.

Positions